Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Compare complete versions: U.S. labeling uses 2-hour infusions, while UCSF uses 3-hour extended infusions. Nebraska separately lists an HD/PD interval different from the label. Do not select a dose from one version and an interval from another.
Check source scope before reading a dose
Avycaz - UCSF Infectious Diseases Management Program
Product / population
UCSF adult institutional protocol for IV ceftazidime/avibactam.
Renal method
Institution-specific intermittent versus continuous hemodialysis.
Source revision
Online guidance checked 2026-11-07; section revision not established.
All record notes are retained here, including notes about sources not selected in this review.
Avycaz - product and source limitations
The FDA label uses a 2-hour infusion. UCSF reports 3 hours and a separate institutional dialysis schedule. Select a complete source before using a dose.
What to reconcile: The FDA label uses a 2-hour infusion. UCSF reports 3 hours and a separate institutional dialysis schedule. Select a complete source before using a dose.
UCSF Infectious Diseases Management Program · UCSF adult institutional protocol for IV ceftazidime/avibactam.
Renal method: Institution-specific intermittent versus continuous hemodialysis. Source date: Online guidance checked 2026-11-07; section revision not established. Retrieved: 2026-11-07
Professional guidance with defined scope. Publication date, institutional setting and source limitations remain controlling. This is not automatic preference over another source.
UCSF administers total combination doses over 3 hours. In intermittent HD it lists 0.94 g IV initially, then each evening. For less severe infection with minimal residual kidney function it gives 0.94 g every 48 hours in the evening as an alternative. Continuous hemodialysis has a separate regimen. This differs from the labeled 2-hour infusion.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
